Suven Pharmaceuticals LimitedGewinn- und Verlustrechnung
| Preis (2025-07-17) | 52W Hoch | 52W Tief |
| 1097 INR | 1.360 INR | 915,75 INR |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - INR | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 382.567.008 | - | - |
Kennzahl in 1000 INR | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|---|---|
Umsatz | - | - | - | - | - | - | - |
Herstellungskosten | - | - | - | - | - | - | - |
Bruttoergebnis | - | - | - | - | - | - | - |
▸ Brutto-Marge | -% | -% | -% | -% | -% | -% | -% |
Betriebliche Aufwendungen | - | - | - | - | - | - | - |
Operativer Gewinn/Verlust | - | - | - | - | - | - | - |
▸ Operative Marge | -% | -% | -% | -% | -% | -% | -% |
Zinsen (Netto) | - | - | - | - | - | - | - |
▸ Zinsausgaben | - | - | - | - | - | - | - |
▸ Zinseinnahmen | - | - | - | - | - | - | - |
Andere Ausgaben | - | - | - | - | - | - | - |
Gewinn vor Steuern | - | - | - | - | - | - | - |
Steueraufwand | - | - | - | - | - | - | - |
Minderheitenanteil | - | - | - | - | - | - | - |
Nettogewinn/-verlust | - | - | - | - | - | - | - |
▸ Netto-Marge | -% | -% | -% | -% | -% | -% | -% |